{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:44:52Z","timestamp":1767894292736,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.eplepsyres.2017.11.001","type":"journal-article","created":{"date-parts":[[2017,11,12]],"date-time":"2017-11-12T08:32:12Z","timestamp":1510475532000},"page":"35-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Utilisation and polypharmacy aspects of antiepileptic drugs in elderly versus younger patients with epilepsy: A pharmacoepidemiological study of CNS-active drugs in Norway, 2004-2015"],"prefix":"10.1016","volume":"139","author":[{"given":"Arton","family":"Baftiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silje Andrea","family":"Feet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l Gunnar","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margrete Larsen","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Henning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"S\u00e6tre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Espen","family":"Molden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Gerd","family":"Granas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svein I.","family":"Johannessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilie Johannessen","family":"Landmark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0005","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0010","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00228-016-2092-3","article-title":"Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-a pharmacoepidemiological study and clinical implications","volume":"72","author":"Baftiu","year":"2016","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.yebeh.2017.01.027","article-title":"Antiseizure, antidepressant, and antipsychotic medication prescribing in elderly nursing home residents","volume":"69","author":"Bathena","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/317859","article-title":"Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis","author":"Beiske","year":"2015","journal-title":"Mult Scler Int."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jad.2009.01.006","article-title":"The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007 \u2212 a prescription database study","volume":"117","author":"Bramness","year":"2009","journal-title":"J Affect Disord."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0030","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/bmj.331.7528.1317","article-title":"Epilepsy in elderly people","volume":"331","author":"Brodie","year":"2005","journal-title":"BMJ ."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eplepsyres.2007.06.012","article-title":"Incidence and prevalence of epilepsy in Denmark","volume":"76","author":"Christensen","year":"2007","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0040","article-title":"The clinical management of bipolar disorder: a review of evidence-based guidelines","volume":"13","author":"Connolly","year":"2011","journal-title":"Prim Care Companion CNS Disord."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0045","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1528-1167.2007.01414.x","article-title":"Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population","volume":"49","author":"Davis","year":"2008","journal-title":"Epilepsia."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0050","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/epi.12557","article-title":"Antiepileptic drug use in seven electronic health record databases in Europe: a methodologic comparison","volume":"55","author":"de Groot","year":"2014","journal-title":"Epilepsia."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0055","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.yebeh.2008.01.003","article-title":"Modern management of epilepsy: a practical approach","volume":"12","author":"Elger","year":"2008","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0060","series-title":"Establishment of the nationwide Norwegian Prescription Database (NorPD)\u2014new opportunities for research in pharmacoepidemiology in Norway","author":"Furu","year":"2008"},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0065","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/epi.13593","article-title":"Antiepileptic drugs and hyponatremia in older adults: Two population-based cohort studies","volume":"57","author":"Gandhi","year":"2016","journal-title":"Epilepsia."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0070","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","article-title":"Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0075","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5153093","article-title":"Prevalence of Different Combinations of Antiepileptic Drugs and CNS Drugs in Elderly Home Care Service and Nursing Home Patients in Norway","author":"Halvorsen","year":"2016","journal-title":"Epilepsy Res Treat."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0080","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1007\/s00415-012-6509-3","article-title":"Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany\u2013a nationwide population-based study in children and adults","volume":"259","author":"Hamer","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1600-0404.2010.01370.x","article-title":"Psychiatric comorbidity and use of psychotropic drugs in epilepsy patients","author":"Henning","year":"2010","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0090","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/bcp.12577","article-title":"Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011","volume":"79","author":"Italiano","year":"2015","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0095","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s40262-013-0067-4","article-title":"Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age: an update","volume":"52","author":"Italiano","year":"2013","journal-title":"Clin Pharmacokinet."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0100","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00228-010-0861-y","article-title":"Psychiatric comorbidity in patients with epilepsy: a population-based study","volume":"66","author":"Karouni","year":"2010","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.seizure.2015.02.017","article-title":"Experience from therapeutic drug monitoring and gender aspects of gabapentin and pregabalin in clinical practice","volume":"28","author":"Landmark","year":"2015","journal-title":"Seizure."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0110","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.addr.2011.10.003","article-title":"Host factors affecting antiepileptic drug delivery-pharmacokinetic variability","volume":"64","author":"Landmark","year":"2012","journal-title":"Adv Drug Deliv Rev."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2009.07.005","article-title":"Antiepileptic drugs in epilepsy and other disorders\u2013a population-based study of prescriptions","volume":"87","author":"Landmark","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1586\/ern.09.136","article-title":"Drug interactions involving the new second- and third-generation antiepileptic drugs","volume":"10","author":"Landmark","year":"2010","journal-title":"Expert Rev Neurother."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.eplepsyres.2011.02.012","article-title":"Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population","volume":"95","author":"Landmark","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1684\/epd.2016.0880","article-title":"Dosing strategies for antiepileptic drugs: from a standard dose for all to individualised treatment by implementation of therapeutic drug monitoring","volume":"18","author":"Landmark","year":"2016","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0135","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1749-6632.2009.05113.x","article-title":"Epilepsy in the elderly","volume":"1184","author":"Leppik","year":"2010","journal-title":"Ann N Y Acad Sci."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/ane.12578","article-title":"Discrepancies between physicians' prescriptions and patients' use of antiepileptic drugs","volume":"135","author":"Mevaag","year":"2017","journal-title":"Acta Neurol Scand."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0145","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2174\/138920008786049311","article-title":"Anticonvulsants \u2212 antidepressants pharmacokinetic drug interactions: the role of the CYP450 system in psychopharmacology","volume":"9","author":"Mula","year":"2008","journal-title":"Curr Drug Metab."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0150","series-title":"Neuropathic pain\u2014pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialist settings","author":"NICE. National Institute for Health and Care Excellence NICE","year":"2017"},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0155","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2125.2010.03619.x","article-title":"Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-07","volume":"70","author":"Oteri","year":"2010","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0160","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s40262-013-0087-0","article-title":"Drug interactions with the newer antiepileptic drugs (AEDs)\u2013 part 1: pharmacokinetic and pharmacodynamic interactions between AEDs","volume":"52","author":"Patsalos","year":"2013","journal-title":"Clin Pharmacokinet."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0165","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s40262-013-0088-z","article-title":"Drug interactions with the newer antiepileptic drugs (AEDs)\u2013Part 2: pharmacokinetic and pharmacodynamic interactions between AEDs and drugs used to treat non-epilepsy disorders","volume":"52","author":"Patsalos","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0170","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/epi.13802","article-title":"Serum protein binding of 25 antiepileptic drugs in a routine clinical setting: A comparison of free non-protein-bound concentrations","volume":"58","author":"Patsalos","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0175","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1528-1167.2007.01128.x","article-title":"An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly","volume":"48","author":"Saetre","year":"2007","journal-title":"Epilepsia."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0180","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1468-1331.2007.01970.x","article-title":"Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000-2005","volume":"14","author":"Savica","year":"2007","journal-title":"Eur J Neurol."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0185","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1528-1167.2009.02516.x","article-title":"Adverse effects of valproate on bone: defining a model to investigate the pathophysiology","volume":"51","author":"Senn","year":"2010","journal-title":"Epilepsia."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/11594710-000000000-00000","article-title":"Clinically significant drug interactions with newer antidepressants","volume":"26","author":"Spina","year":"2012","journal-title":"CNS Drugs."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0195","series-title":"Statistics Norway Population data","author":"SSB","year":"2017"},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0404.2010.01464.x","article-title":"Epilepsy in the elderly: facts and challenges","volume":"124","author":"Stefan","year":"2011","journal-title":"Acta Neurol Scand."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0205","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/j.1528-1167.2007.01222.x","article-title":"Psychiatric comorbidity in epilepsy: a population-based analysis","volume":"48","author":"Tellez-Zenteno","year":"2007","journal-title":"Epilepsia."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0210","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1600-0404.2006.00639.x","article-title":"Trends in utilization of antiepileptic drugs in Denmark","volume":"113","author":"Tsiropoulos","year":"2006","journal-title":"Acta Neurol Scand."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0215","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/pds.3457","article-title":"The Nordic prescription databases as a resource for pharmacoepidemiological research\u2013a literature review","volume":"22","author":"Wettermark","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0220","series-title":"Definition of elderly","author":"WHO, World Heatlh Organisation","year":"2016"},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0225","series-title":"Definition of Pharmacovigilance","author":"WHO, World Health Organisation","year":"2017"},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2008.01146.x","article-title":"Neurological comorbidity and epilepsy: implications for treatment","volume":"120","author":"Zaccara","year":"2009","journal-title":"Acta Neurol Scand."},{"key":"10.1016\/j.eplepsyres.2017.11.001_bib0235","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1684\/epd.2014.0714","article-title":"Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs","volume":"16","author":"Zaccara","year":"2014","journal-title":"Epileptic Disord."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121117304023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121117304023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:38:01Z","timestamp":1760276281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121117304023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":47,"alternative-id":["S0920121117304023"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.11.001","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilisation and polypharmacy aspects of antiepileptic drugs in elderly versus younger patients with epilepsy: A pharmacoepidemiological study of CNS-active drugs in Norway, 2004-2015","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}